|
| 37652123 | Which trial do we need? A sequential multiple assignment randomized trial to determine the optimal Clostridioides difficile treatment sequence. | Clin Microbiol Infect | 2024 |
| 38078766 | Comparison of <i>Clostridioides difficile</i> nucleic acid amplification test (NAAT) results using fresh and frozen stool specimens and rectal swabs. | J Clin Microbiol | 2024 |
| 34990593 | Qualitative and quantitative detection of SARS-CoV-2 antibodies from dried blood spots. | Clin Biochem | 2023 |
| 37953814 | Duvelisib for Critically Ill Patients With Coronavirus Disease 2019: An Investigator-Initiated, Randomized, Placebo-Controlled, Double-Blind Pilot Trial. | Open Forum Infect Dis | 2023 |
| 37855077 | Introduction to <i>A Compendium of Strategies to Prevent Healthcare-Associated Infections In Acute-Care Hospitals: 2022 Updates</i>. | Infect Control Hosp Epidemiol | 2023 |
| 37771748 | Impact of the Severe acute respiratory syndrome coronavirus 2 pandemic on mortality associated with healthcare-associated infections. | Antimicrob Steward Healthc Epidemiol | 2023 |
| 37496610 | Healthcare Costs of <i>Clostridioides difficile</i> Infection in Commercially Insured Younger Adults. | Open Forum Infect Dis | 2023 |
| 37564743 | Effect of Fecal Microbiota, Live-Jslm (REBYOTA [RBL]) on Health-Related Quality of Life in Patients With Recurrent <i>Clostridioides difficile</i> Infection: Results From the PUNCH CD3 Clinical Trial. | Open Forum Infect Dis | 2023 |
| 37381734 | Early coronavirus disease 2019 (COVID-19) pandemic effects on individual-level risk for healthcare-associated infections in hospitalized patients. | Infect Control Hosp Epidemiol | 2023 |
| 37210680 | Economic Impact of Recurrent Clostridioides difficile Infection in the USA: A Systematic Literature Review and Cost Synthesis. | Adv Ther | 2023 |
| 36978404 | Microbiology Clinical Culture Diagnostic Yields and Antimicrobial Resistance Proportions before and during the COVID-19 Pandemic in an Indian Community Hospital and Two US Community Hospitals. | Antibiotics (Basel) | 2023 |
| 37042243 | Strategies to prevent <i>Clostridioides difficile</i> infections in acute-care hospitals: 2022 Update. | Infect Control Hosp Epidemiol | 2023 |
| 37333464 | Safety of fecal microbiota, live-jslm (REBYOTA<sup>â¿¢</sup>) in individuals with recurrent <i>Clostridioides difficile</i> infection: data from five prospective clinical trials. | Therap Adv Gastroenterol | 2023 |
| 36968968 | Effect of fecal microbial transplantation on <i>Clostridioides difficile</i> infection: dysbiosis, metabolites and health related quality of life. | Open Forum Infect Dis | 2023 |
| 37199652 | Evaluation of the NG-Test CARBA 5 Lateral Flow Assay with an IMP-27-Producing Morganella morganii and Other <i>Morganellaceae</i>. | Microbiol Spectr | 2023 |
| 37263419 | Risk factors for hospital-onset Clostridioides difficile infections before and during the severe acute respiratory syndrome coronavirus 2 pandemic. | Am J Infect Control | 2023 |
| 37062301 | Redefining Clostridioides difficile infection antibiotic response and clinical outcomes. | Lancet Infect Dis | 2023 |
| 36785770 | The impact on central line-associated bloodstream infection rates following the introduction of a closed system transfer device in oncology wards. | Infect Prev Pract | 2023 |
| 36544075 | Final Results from a Phase 2b Randomized, Placebo-Controlled Clinical Trial of RBX2660: A Microbiota-Based Drug for the Prevention of Recurrent Clostridioides difficile Infection. | Infect Dis Ther | 2023 |
| 36714284 | Healthcare-associated infections (HAIs) during the coronavirus disease 2019 (COVID-19) pandemic: A time-series analysis. | Antimicrob Steward Healthc Epidemiol | 2023 |
| 36702174 | Walk before you run: Feasibility challenges and lessons learned from the PROCLAIM study, a multicenter randomized controlled trial of misoprostol for prevention of recurrent Clostridioides difficile during COVID-19. | Anaerobe | 2023 |
| 36493966 | Risk factors for hospital-acquired infection during the SARS-CoV-2 pandemic. | J Hosp Infect | 2023 |
| 36791167 | Oral Vancomycin as Secondary Prophylaxis for Prevention of Recurrent <i>Clostridioides difficile</i> Infection. | N Engl J Med | 2023 |
| 36285546 | Costs Attributable to Clostridioides difficile Infection Based on the Setting of Onset. | Clin Infect Dis | 2023 |
| 36082779 | Trends in the incidence of <i>Clostridioides difficile</i> infection in adults and the elderly insured by Medicaid compared to commercial insurance or Medicare only. | Infect Control Hosp Epidemiol | 2023 |
| 34628418 | Can prediction scores be used to identify patients at risk of Clostridioides difficile infection? | Curr Opin Gastroenterol | 2022 |
| 35545083 | Persisting uropathogenic Escherichia coli lineages show signatures of niche-specific within-host adaptation mediated by mobile genetic elements. | Cell Host Microbe | 2022 |
| 35344961 | Kidney Transplantation from COVID-19 Deceased Donors: New Hope on the Horizon. | Am J Nephrol | 2022 |
| 35417701 | Acute and persistent effects of commonly used antibiotics on the gut microbiome and resistome in healthy adults. | Cell Rep | 2022 |
| 35777486 | Serological detection of antibodies to the SARS-CoV-2 nucleocapsid protein from dried blood spots. | Clin Biochem | 2022 |
| 35993734 | Epidemiology of Plasmid Lineages Mediating the Spread of Extended-Spectrum Beta-Lactamases among Clinical Escherichia coli. | mSystems | 2022 |
| 36267250 | Impact of Updated Clinical Practice Guidelines on Outpatient Treatment for <i>Clostridioides difficile</i> Infection and Associated Clinical Outcomes. | Open Forum Infect Dis | 2022 |
| 33820576 | A randomized controlled trial of <i>Lactobacillus rhamnosus</i> GG on antimicrobial-resistant organism colonization. | Infect Control Hosp Epidemiol | 2022 |
| 35279084 | Durable reduction of Clostridioides difficile infection recurrence and microbiome restoration after treatment with RBX2660: results from an open-label phase 2 clinical trial. | BMC Infect Dis | 2022 |
| 35202891 | American Society for Transplantation and Cellular Therapy Series: #5-Management of Clostridioides difficile Infection in Hematopoietic Cell Transplant Recipients. | Transplant Cell Ther | 2022 |
| 35083969 | Multi-omics investigation of <i>Clostridioides difficile</i>-colonized patients reveals pathogen and commensal correlates of <i>C. difficile</i> pathogenesis. | Elife | 2022 |
| 34609483 | Alternative Causes of Infectious Diarrhea in Patients with Negative Tests for Clostridoides Difficile. | J Appl Lab Med | 2022 |
| 32766672 | Clostridioides difficile Infections in Inpatient Pediatric Oncology Patients: A Cohort Study Evaluating Risk Factors and Associated Outcomes. | J Pediatric Infect Dis Soc | 2021 |
| 33593430 | Microbiota restoration reduces antibiotic-resistant bacteria gut colonization in patients with recurrent Clostridioides difficile infection from the open-label PUNCH CD study. | Genome Med | 2021 |
| 33512073 | Repeat SARS-CoV-2 testing after recovery. Is a pretransplant PCR necessary? | Am J Transplant | 2021 |
| 34251073 | The role of chronic suppressive antibiotics therapy in superficial drive line infection relapse of left ventricular assist devices: A retrospective cohort from a tertiary care center. | Transpl Infect Dis | 2021 |
| 31925953 | Epidemiology of Left Ventricular Assist Device Infections: Findings From a Large Nonregistry Cohort. | Clin Infect Dis | 2021 |
| 33441409 | Randomized Controlled Trial of Oral Vancomycin Treatment in Clostridioides difficile-Colonized Patients. | mSphere | 2021 |
| 32860846 | Impact of no-touch ultraviolet light room disinfection systems on Clostridioides difficile infections. | Am J Infect Control | 2021 |
| 31542458 | Risk factors for Clostridioides difficile infection in hospitalized patients and associated mortality in Japan: a multi-centre prospective cohort study. | J Hosp Infect | 2020 |
| 31969206 | Assessment of antibiotic-resistant organism transmission among rooms of hospitalized patients, healthcare personnel, and the hospital environment utilizing surrogate markers and selective bacterial cultures. | Infect Control Hosp Epidemiol | 2020 |
| 31806059 | Antibiotic stewardship teams and <i>Clostridioides difficile</i> practices in United States hospitals: A national survey in The Joint Commission antibiotic stewardship standard era. | Infect Control Hosp Epidemiol | 2020 |
| 31976779 | Strategies to prevent adverse outcomes following <i>Clostridioides difficile</i> infection in the elderly. | Expert Rev Anti Infect Ther | 2020 |
| 33115427 | Comparing intervention strategies for reducing Clostridioides difficile transmission in acute healthcare settings: an agent-based modeling study. | BMC Infect Dis | 2020 |
| 32862830 | Impact of investigational microbiota therapeutic RBX2660 on the gut microbiome and resistome revealed by a placebo-controlled clinical trial. | Microbiome | 2020 |